Tuberculosis is the second most infectious deadly disease after COVID-19, so why has it been met with political inertia? Vinny Wooding, Senior Parliamentary Advocacy Officer at RESULTS UK, discusses the burden of TB and the rapid action needed to address this global threat.
Ruplekha Choudhurie, Senior Industry Analyst/Team Lead, walks us through nanomedicine, explaining a multipronged approach to tackle infectious diseases.
HPV is the most common STI in the world, affecting 80% of the population. Here Dr Deborah Lee, from Dr Fox Online Pharmacy, addresses the most common issues about HPV in an attempt to aid in the understanding of the condition
Wendy Harrison, CEO of the SCI Foundation, outlines the importance of putting parasitic infections on the map, with a particular focus on schistosomiasis.
Dr Zisis Kozlakidis and Dr Dewi Nur Aisyah examine Hepatitis C virus elimination and weigh up if this has the potential to become a global success story.
Chief of the Bacterial Diseases Branch, Division of Vector-Borne Diseases at the Centers for Disease Control & Prevention, walks us through a growing health problem in the United States, tickborne diseases.
One in eight adults (12.7%) who are infected with SARS-CoV-2 experience long COVID symptoms, including chest pain, difficulties breathing, painful muscles and more.
